These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2938343)

  • 1. Disposition and biotransformation of 14C-etodolac in man.
    Ferdinandi ES; Sehgal SN; Demerson CA; Dubuc J; Zilber J; Dvornik D; Cayen MN
    Xenobiotica; 1986 Feb; 16(2):153-66. PubMed ID: 2938343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic disposition of etodolac in rats, dogs, and man.
    Cayen MN; Kraml M; Ferdinandi ES; Greselin E; Dvornik D
    Drug Metab Rev; 1981; 12(2):339-62. PubMed ID: 6461537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and biotransformation of the antiretroviral drug nevirapine in humans.
    Riska P; Lamson M; MacGregor T; Sabo J; Hattox S; Pav J; Keirns J
    Drug Metab Dispos; 1999 Aug; 27(8):895-901. PubMed ID: 10421616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of the phase II metabolites of the non steroidal anti-inflammatory drug etodolac in human urine.
    Berendes U; Blaschke G
    Enantiomer; 1996; 1(4-6):415-22. PubMed ID: 9676278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects.
    Hoffmann M; DeMaio W; Jordan RA; Talaat R; Harper D; Speth J; Scatina J
    Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition and metabolic fate of 14C-cibenzoline in man.
    Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
    Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjects.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1990; 18(1):28-35. PubMed ID: 1970774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic fate of 14C-ximoprofen in rats, baboons and humans.
    Mayo BC; Chasseaud LF; Hawkins DR; Taylor IW; Legeai J
    Xenobiotica; 1990 Mar; 20(3):233-46. PubMed ID: 2336835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disposition of clavulanic acid in man.
    Bolton GC; Allen GD; Davies BE; Filer CW; Jeffery DJ
    Xenobiotica; 1986 Sep; 16(9):853-63. PubMed ID: 3765664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 14C-thymoxamine in rat and man.
    Duchene P; Bernouillet C; Bromet-Petit M; Mosser J; Feniou C; Gaudin D; Virelizier H
    Xenobiotica; 1988 Aug; 18(8):919-28. PubMed ID: 2973182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ractopamine hydrochloride metabolites excreted in rat bile.
    Smith DJ; Giddings JM; Feil VJ; Paulson GD
    Xenobiotica; 1995 May; 25(5):511-20. PubMed ID: 7571724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation and elimination of 14C-flecainide acetate in humans.
    McQuinn RL; Quarfoth GJ; Johnson JD; Banitt EH; Pathre SV; Chang SF; Ober RE; Conard GJ
    Drug Metab Dispos; 1984; 12(4):414-20. PubMed ID: 6148206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.